TQT Study

2 clinical trials · Condition

Record	Firm	Date
A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects (NCT04238195)	Spero Therapeutics	2020-01-19
A Phase 1, Single Ascending Dose, Randomized, Double-Blind, Placebo and Positive Controlled Study to Evaluate the Cardiovascular Effect of Tetrodotoxin in Healthy Adult Subjects (NCT04083833)	Wex Pharmaceuticals Inc.	2018-02-07

Every clearance here is in the API, with alerts when new ones post.